Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$14.1M Sell
144,076
-84,256
-37% -$9.46M 0.01% 1182
2014
Q2
$29.3M Sell
228,332
-25,988
-10% -$3.25M 0.02% 685
2014
Q1
$31.2M Sell
254,320
-19,175
-7% -$2.2M 0.03% 587
2013
Q4
$30M Buy
273,495
+40,683
+17% +$4.07M 0.03% 602
2013
Q3
$22.6M Buy
232,812
+23,155
+11% +$2.13M 0.02% 655
2013
Q2
$18.8M Buy
+209,657
New +$17.3M 0.02% 680

Other funds holding ENOV

UBS's ENOV Position: Q3 2014 in Review

UBS reduced its Enovis (ENOV) stake by 37% in Q3 2014, selling an estimated $9.46M and leaving 144,076 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #1182.

UBS first reported a position in ENOV in Q2 2013 and has held it in 6 quarters since. The position peaked at $31.2M in Q1 2014. 212 funds tracked by Wall St. Rank hold ENOV as of Q3 2014.

  • UBS held 144,076 shares of Enovis worth $14.1M as of Q3 2014.
  • UBS sold 84,256 Enovis shares in Q3 2014, an estimated $9.46M.
  • Enovis made up 0.01% of UBS's portfolio in Q3 2014, its #1182 holding.
  • UBS first reported a position in Enovis in Q2 2013 and has held it in 6 quarters since.
  • UBS's Enovis position peaked at $31.2M in Q1 2014.
  • 212 funds tracked by Wall St. Rank held Enovis as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.